NSE ScannerOpen the scanner

Pharmaceuticals · Pharmaceuticals: Major · NSE: LASA · data 2026-10-30

Lasa Supergenerics Ltd.

₹4.67-4.89% on 26 OctHealth: Weak 0/10
Nov 2025Low ₹4.67 · High ₹12.04-54.7%

In plain words

Price: 62.6% below its 52-week high of ₹12.48.

Delivery: 80.4% of traded shares were kept for delivery over the last 10 sessions, against 70.8% over the last 60.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price
₹4.67
Market cap
₹25 cr
P/E
—
P/B
—
ROE
-51.1%
ROCE
-27.0%
Debt / equity
0.2
Dividend yield
0.00%
1-year return
-55.1%
52-week high
₹12.48
52-week low
₹4.67
Operating margin
-224.5%

Growth

Revenue (last 12 months)₹6 cr
Net profit (last 12 months)₹-17 cr
Sales growth, 3 years (yearly)-42.1%
Profit growth, 3 years (yearly)—

Smart-money activity

5/100 · Weak over the last ~60 sessions, data 2026-10-26

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Common questions

Is Lasa Supergenerics Ltd. debt-free?

Its latest reported debt-to-equity ratio is 0.2.

What is the 52-week high and low of Lasa Supergenerics Ltd.?

The 52-week high is ₹12.48 and the 52-week low is ₹4.67.

Similar companies

Mangalam Drugs & Organics Ltd. (MANGALAM) · Biofil Chemicals & Pharmaceuticals Ltd. (BIOFILCHEM) · Medicamen Organics Ltd. (MEDIORG) · Medi-Caps Ltd. (MEDICAPQ) · Sunrest Lifescience Limited (SUNREST)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open LASA in NSE Scanner →
Share on WhatsAppShare on Telegram